This study is in progress, not accepting new patients
Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT02435212
- Phase
- Phase 2 Anemia Research Study
- Study Type
- Interventional
- Participants
- About 224 people participating
- Last Updated